Consumer Driven Health Care

Lawmakers should take "bold steps" to strengthen employer plans, reduce costs, promote telehealth and combat the mental health crisis, wrote the American Benefits Council in a letter.

Just days after the other two drugmakers dropped their prices, Sanofi is capping the cost of its most prescribed insulin at $35 for the privately insured, as a price gouging lawsuit against all three drugmakers gets underway.

The leaders from various sectors of the health care industry sent a letter to the Centers for Medicare & Medicaid Services in support of the proposed Medicare Advantage payment policy changes for 2024.

Planning for compliance obligations when the PHE ends will require a review of legislation passed between 2020 and 2023.

A new report finds that brokers and agents say that carriers are incentivizing the sale of certain types of Medicare plans over others.

The battle over access to a key drug used for medication abortions heats up in a Texas courtroom, as Senators send a letter to Walgreens over its recent announcement that it will not dispense abortion pills in 20 states.